DUBLIN--(http://www.researchandmarkets.com/research/wxnq79/global_h1n1) has announced the addition of the "Global H1N1 Vaccines Market 2011-2015" report to their offering.)--Research and Markets (
One of the key factors contributing to this market growth is the increased awareness among people in developed nations. The Global H1N1 Vaccines market has also been witnessing the trend of Pre-pandemic vaccinations. However, the easing pandemic situation could pose a challenge to the growth of this market.
The key vendors dominating this market space are AstraZeneca plc., GlaxoSmithKline plc., Merck and Co. Inc., Novartis AG, Sanofi AG.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''In most of the developed countries, there is an increased focus on pre-pandemic vaccination. Various governing bodies are aiming at immunizing people years in advance against a flu pandemic. The focus is to avoid a rush to create vaccines once a new pandemic starts. Vaccine manufacturers are involved in producing pre-pandemic vaccines for better preparedness for the next major outbreak.''
According to the report, one of the key drivers witnessed in this market is the increase in the awareness among people in developed nations. As a result of the growing level of awareness, many people are getting themselves and their family vaccinated on their own accord. Significant support from both governmental and non-governmental agencies is helping to educate the public regarding the importance of personal hygiene. These agencies are also helping in educating the people about various vaccines available against the H1N1 virus.
Further, the report reveals that one of the key challenges is the easing pandemic situation.
For more information visit http://www.researchandmarkets.com/research/wxnq79/global_h1n1